Related Experiment Video
Updated: Sep 3, 2025

Visualization of SARS-CoV-2 using Immuno RNA-Fluorescence In Situ Hybridization
Published on: December 23, 2020
The SARS-CoV-2 targeted human RNA binding proteins network biology to investigate COVID-19 associated manifestations
Kartikay Prasad1, Pratibha Gour2, Saurabh Raghuvanshi2
1Amity Institute of Neuropsychology & Neurosciences, Amity University, Noida, UP 201303, India.
Abstract:
The global coronavirus disease 2019 (COVID-19) pandemic caused by the SARS-CoV-2 virus has had unprecedented social and economic ramifications. Identifying targets for drug repurposing could be an effective means to present new and fast treatments. Furthermore, the risk of morbidity and mortality from COVID-19 goes up when there are coexisting medical conditions, however, the underlying mechanisms remain unclear. In the current study, we have adopted a network-based systems biology approach to investigate the RNA binding proteins (RBPs)-based molecular interplay between COVID-19, various human cancers, and neurological disorders. The network based on RBPs commonly involved in the three disease conditions consisted of nine RBPs connecting 10 different cancer types, 22 brain disorders, and COVID-19 infection, ultimately hinting at the comorbidities and complexity of COVID-19. Further, we underscored five miRNAs with reported antiviral properties that target all of the nine shared RBPs and are thus therapeutically valuable. As a strategy to improve the clinical conditions in comorbidities associated with COVID-19, we propose perturbing the shared RBPs by drug repurposing. The network-based analysis presented hereby contributes to a better knowledge of the molecular underpinnings of the comorbidities associated with COVID-19.
Insights
This study reveals shared RNA binding proteins (RBPs) linking COVID-19, cancer, and neurological disorders. Targeting these RBPs through drug repurposing may offer new therapeutic strategies for COVID-19 comorbidities.
Area of Science:
- Biomedical research
- Systems biology
- Network analysis
Background:
- The COVID-19 pandemic presents significant social and economic challenges.
- Understanding COVID-19 comorbidities is crucial for effective treatment.
- Drug repurposing offers a rapid therapeutic development pathway.
Purpose of the Study:
- To investigate the molecular interplay between COVID-19, cancers, and neurological disorders.
- To identify shared RNA binding proteins (RBPs) implicated in these conditions.
- To explore therapeutic strategies for COVID-19 comorbidities.
Main Methods:
- A network-based systems biology approach was employed.
- Analysis focused on RNA binding proteins (RBPs) common to COVID-19, cancers, and neurological disorders.
- Identification of microRNAs (miRNAs) targeting shared RBPs.
Main Results:
- A network of nine RBPs was identified, connecting COVID-19 with 10 cancer types and 22 brain disorders.
- Five antiviral miRNAs targeting these shared RBPs were highlighted.
- The findings suggest a complex molecular basis for COVID-19 comorbidities.
Conclusions:
- Shared RBPs play a significant role in the comorbidities associated with COVID-19.
- Targeting these RBPs via drug repurposing presents a promising therapeutic avenue.
- This network-based analysis enhances understanding of COVID-19's molecular underpinnings.
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
Leaky Scanning
Conjugated Proteins
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Viruses with RNA Genomes

